Literature DB >> 19896734

Hypercholesterolemia and hypoadiponectinemia are associated with necrotic core-rich coronary plaque.

Shinobu Kojima1, Sunao Kojima, Hidetomo Maruyoshi, Yasuhiro Nagayoshi, Koichi Kaikita, Hitoshi Sumida, Seigo Sugiyama, Tohru Funahashi, Hisao Ogawa.   

Abstract

BACKGROUND: Hypercholesterolemia is a risk factor for coronary artery disease and closely linked to unstable plaque. Hypoadiponectinemia is frequently observed in patients with metabolic syndrome complicated with macroangiopathy and predicts poor clinical outcome. Spectral analysis of intravascular ultrasonography radiofrequency (IVUS-Virtual Histology [VH]) allows quantitative analysis of plaque composition. The purpose of this study was to verify the effects of low-density lipoprotein (LDL) cholesterol level on plaque morphology, and test the hypothesis that adiponectin influences coronary plaque volume and composition.
METHODS: Preintervention IVUS-VH using a continuous pullback was performed in 92 coronary vessels in 92 patients with coronary artery disease. The morphological distribution of plaque was evaluated prospectively in a 60-mm segment of coronary vessels containing the culprit lesion.
RESULTS: Serum LDL cholesterol levels correlated positively with necrotic core volume (r = 0.217, P = 0.037) and percent necrotic core tissue (r = 0.308, P = 0.003), while plasma adiponectin levels correlated negatively with plaque volume (r = -0.297, P = 0.004) and necrotic core volume (r = -0.306, P = 0.003). Multiple regression analyses showed close association between necrotic core volume and statin-use (β = -21.68, P = 0.004) and adiponectin levels (β = -31.25, P = 0.038), and that percent necrotic core tissue was influenced by statin-use (β = -4.595, P = 0.026) and LDL cholesterol levels (β = 0.092, P = 0.031).
CONCLUSIONS: Adiponectin is closely linked to coronary plaque volume. Hypercholesterolemia and hypoadiponectinemia correlate with necrotic core lesions and may contribute to increased risk of coronary plaque vulnerability. Statins can affectively prevent necrotic core plaque formation associated with hypercholesterolemia and hypoadiponectinemia.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19896734     DOI: 10.1016/j.ijcard.2009.09.536

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

Review 1.  The evolving role of adiponectin as an additive biomarker in HFrEF.

Authors:  Tahnee Sente; Andreas Gevaert; An Van Berendoncks; Christiaan J Vrints; Vicky Y Hoymans
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

2.  Correlation of the characteristics of symptomatic intracranial atherosclerotic plaques with stroke types and risk of stroke recurrence: a cohort study.

Authors:  Huayun Jiang; Kaixuan Ren; Tiantian Li; Chengqun Qian; Shenchu Gong; Tianle Wang; Li Zhu
Journal:  Ann Transl Med       Date:  2022-06

3.  Contribution of adiponectin polymorphisms to the risk of coronary artery disease in a North-African Tunisian population.

Authors:  Lakhdar Ghazouani; Afoua Elmufti; Intissar Baaziz; Ibtissem Chaabane; Hedi Ben Mansour
Journal:  J Clin Lab Anal       Date:  2018-04-06       Impact factor: 2.352

4.  LDL-C and Total Stent Length are Independent Predictors of Periprocedural Myocardial Injury and Infarction for Unstable Angina Patients Undergoing Elective Percutaneous Coronary Intervention.

Authors:  Xuefeng Chen; Chunli Rong; Peng Qi; Wenlou Bai; Wenjing Yao; Yantao Zhang; Yi Dang
Journal:  Int J Gen Med       Date:  2021-04-16

5.  Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromes.

Authors:  Kozo Okada; Kiyoshi Hibi; Masaomi Gohbara; Shunsuke Kataoka; Keiko Takano; Eiichi Akiyama; Yasushi Matsuzawa; Kenichiro Saka; Nobuhiko Maejima; Mitsuaki Endo; Noriaki Iwahashi; Kengo Tsukahara; Masami Kosuge; Toshiaki Ebina; Peter J Fitzgerald; Yasuhiro Honda; Satoshi Umemura; Kazuo Kimura
Journal:  Cardiovasc Diabetol       Date:  2015-08-20       Impact factor: 9.951

6.  Nutrients restriction upregulates adiponectin in epicardial or subcutaneous adipose tissue: impact in de novo heart failure patients.

Authors:  Rosa M Agra; Ángel Fernández-Trasancos; Esther Díaz-Rodríguez; Alberto Cordero; Alfonso Varela-Román; Inés Gómez-Otero; J Nicolás López- Canoa; Ángel Luis Fernández; José Manuel Martínez-Cereijo; José Ramón González-Juanatey; Sonia Eiras
Journal:  Int J Med Sci       Date:  2018-02-12       Impact factor: 3.738

7.  Coronary flow impairment in asymptomatic patients with early stage type-2 diabetes: Detection by FFRCT.

Authors:  Monija Mrgan; Bjarne Linde Nørgaard; Damini Dey; Jørgen Gram; Michael Hecht Olsen; Jeppe Gram; Niels Peter Rønnow Sand
Journal:  Diab Vasc Dis Res       Date:  2020 Sep-Oct       Impact factor: 3.291

8.  Association between apolipoprotein B/A1 ratio and coronary plaque vulnerability in patients with atherosclerotic cardiovascular disease: an intravascular optical coherence tomography study.

Authors:  Fuxue Deng; Danni Li; Lei Lei; Qiang Yang; Qing Li; Hongtao Wang; Jie Deng; Qiangsun Zheng; Wei Jiang
Journal:  Cardiovasc Diabetol       Date:  2021-09-15       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.